4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000060
Chief Medical Officer sold 4,189 shares at an average $17.46 ($73,130)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ho Carole · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-13 | Sale : show line 1 in the form 10b5-1 | −2,784 | $17.29 | $48,135 | 145,010 | D |
| 2024-02-14 | Sale : show line 2 in the form 10b5-1 | −1,405 | $17.79 | $24,995 | 143,605 | D |
| Open-market sales · 4,189 sh · avg $17.46 · $73,130 | ||||||
Loading xslF345X05/wk-form4_1708049673.xml…